Global Medical REIT Inc. held its 2024 Annual Meeting where stockholders approved an amendment to the 2016 Equity Incentive Plan to increase the number of shares reserved for issuance by 1,500,000 shares, elected directors, approved executive compensation, recommended annual advisory votes on executive compensation, and ratified the appointment of Deloitte & Touche LLP as the independent registered public accounting firm.